ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N05AX13 | B | Paliperidone palmitate - 50mg | 6799/945 | 97852/11 | INVEGA SUSTENNA | 50mg | 1 + 2needles | Injectable suspension, prolonged release | IM | Mersaco | Janssen Pharmaceutica NV | Belgium | 16,769,688 L.L | 19.35 | D | Janssen Cilag International NV | Belgium | 05/02/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N05AX13 | B | Paliperidone palmitate - 50mg | 6799 | 97852/11 | INVEGA SUSTENNA | 50mg | 1 + 2needles | Injectable suspension, prolonged release | IM | Mersaco | Janssen Pharmaceutica NV | Belgium | 5,602,388 L.L | 19.35 | D | Janssen Cilag International NV | Belgium | 05/02/20 | 80 |